Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Sep 10, 2026, 4:00 PM EDT
1.160
-0.040 (-3.33%)
Pre-market: Sep 11, 2026, 4:00 AM EDT
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$929,850
Market Cap
4.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | 1 | 12.50% |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| PMGC Holdings | 34 |
| Cardio Diagnostics Holdings | 17 |
| VivoSim Labs | 15 |
| Processa Pharmaceuticals | 12 |
| Can-Fite BioPharma | 5 |
| Cadrenal Therapeutics | 5 |
| Pulmatrix | 2 |
DRMA News
- 16 days ago - Dermata Therapeutics announces commercial launch of Tome Foundational Treatment - TheFly
- 16 days ago - Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment - Accesswire
- 20 days ago - Dermata Therapeutics announces Tome Foundational Treatment open to preorders - TheFly
- 20 days ago - Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Accesswire
- 24 days ago - Dermata Therapeutics prices 2.29M shares at $1.46 in private placement - TheFly
- 24 days ago - Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 4 weeks ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - Accesswire
- 4 weeks ago - Dermata Therapeutics Earnings release: Q2 2026 - Filings